Dia****ic footwear with distinct vital components such as raw material and comfort are becoming increasingly popular among dia****es patients worldwide.
They help to reduce the risk of skin damage in dia****ic patients with pre-existing diet issues.
The global dia****ic shoes market trend is expected to grow at 6.4% CAGR during the forecast period of 2022-2032, opines Future Market Insights (FMI).
The overall demand in the market is driven by increased innovation by major players to offer personalized and attractive dia****ic footwear to meet the latest fashion trends, particularly among the female population.
The quality of life of dia****ic patients have improved dramatically when they use dia****ic shoes on a regular basis.
Adoption of these shoes is also increasing as they are cost-effective with professional care services such as dia****ic foot ulcer treatment and amputations.
This aspect is expected to boost the dia****ic footwear sales in the coming years. Further, increased demand for unique designs and comfort will benefit the global dia****ic shoe market.
Growing awareness for health and easy availability is expected to improve the demand for dia****ic shoes.
Additionally, market participants are providing more tailored dia****ic shoes as a result of growing awareness among dia****es patients.
Wellness Dia****es, for instance, offers high-quality footwear made of micro cellular polymer that is personalized for patients with calluses, corns, or other foot deformities.
On the back of these aforementioned factors, the global dia****ic shoes market is estimated to surpass US$ 14.9 Bn by the end of 2032.
Key Takeaways
Dress shoes are predicted to account for the majority of the market in terms of type owing to the increased awareness regarding living a healthy and active lifestyle.
In terms of width, the medium width segment is held a significant share of 29.5% in 2021.
Based on end user, women are predicted to hold a considerable proportion of the end-user market due to the increased prevalence of dia****es among women
Based on patient type, the outpatient category is expected to grow rapidly with a CAGR of 8.3% during the projection period.
The U.S. held a noteworthy value share of 67.6% in North America in 2021 owing to the rising prevalence of dia****es in the country.
Who is winning?
Leading manufacturers of dia****ic shoes are focused on aggressive promotional strategies, advertisements, and new product launches that have driven sales growth of dia****ic shoes globally.
Major players present in the dia****ic shoes market are Daifuku, DJO, LLC (Dr. Comfort), Drewshoe, Incorporated, Orthofeet Inc., DARCO International, Inc., Clearwell Mobility Company, Supad, Aetrex Worldwide, Inc., Gravity Defyer Corp., Kinetec Medical Products Ltd, Horng Shin Footwear Co., Watts Footwear, ASICS Corporation, Advance Dia****ic Solution, Dr Zen Products, Inc., Sensoria Health among others.
Get More Valuable Insights
Future Market Insights, in its new offering, provides an unbiased analysis of the global dia****ic shoes market, presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.
The study divulges compelling insights on the dia****ic shoes market based on the product type (dress shoes, running shoes, strolling shoes, others) patient type (outpatient & inpatient) end user (men & women) width (narrow, medium, wide and others) and sales channel (direct sales, footwear specialty stores, medical & healthcare centres, online retailers, mono-brand stores & other sales channel) across seven major regions
Global Dia****ic Shoes Market By Category
By Product Type:
Dress Shoes
Running Shoes
Strolling Shoes
Others
By Patient Type:
Outpatient
Inpatient
By End User:
Men
Women
By Width:
Narrow
Medium
Wide
Others
By Sales Channel:
Direct Sales
Footwear Specialty Stores
Medical & Healthcare Centres
Online Retailers
Mono-Brand Stores
Other Sales Channel
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA
For More Information @ https://www.futuremarketinsigh....ts.com/reports/dia**
